Hangzhou Tigermed Consulting Co., Ltd
300347
शेयरों में रैंक
#3216
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides... Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
शेयर मूल्य
$7.44
मार्केट कैप
$5.49B
बदलाव (1 दिन)
-2.99%
बदलाव (1 वर्ष)
-0.42%
देश
CN
व्यापार Hangzhou Tigermed Consulting Co., Ltd (300347)
श्रेणी
Healthcare
Hangzhou Tigermed Consulting Co., Ltd (300347) के लिए बकाया शेयरों की संख्या
June 2026 की स्थिति में बकाया शेयरों की संख्या: 836.35M
Hangzhou Tigermed Consulting Co., Ltd की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी के वर्तमान बकाया शेयरों की संख्या 836.35M है। December 2024 के अंत में कंपनी के पास 863.04M बकाया शेयर थे। बकाया शेयरों की संख्या आमतौर पर शेयर स्प्लिट्स और शेयर बायबैक से प्रभावित होती है।
Hangzhou Tigermed Consulting Co., Ltd (300347) के लिए 2009 से 2026 तक बकाया शेयरों का इतिहास
प्रत्येक वर्ष के अंत में बकाया शेयर
| वर्ष | बकाया शेयर | परिवर्तन |
|---|---|---|
| 2026 (TTM) | 836.35M | -2.04% |
| 2025 | 853.74M | -1.08% |
| 2024 | 863.04M | -0.22% |
| 2023 | 864.95M | -0.69% |
| 2022 | 870.96M | 9.01% |
| 2020 | 798.98M | 7.27% |
| 2019 | 744.81M | -0.63% |
| 2018 | 749.50M | 1.26% |
| 2017 | 740.14M | 5.24% |
| 2016 | 703.26M | 8.00% |
| 2015 | 651.16M | 0.30% |
| 2014 | 649.23M | 1.26% |
| 2013 | 641.15M | 20.16% |
| 2012 | 533.60M | 10.72% |
| 2011 | 481.93M | 1.32% |
| 2010 | 475.64M | 16.86% |
| 2009 | 407.01M | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के लिए बकाया शेयर
| कंपनी | बकाया शेयर | अंतर | देश |
|---|---|---|---|
| 253.90M | -69.64% |
US
|
|
| 396.00M | -52.65% |
US
|
|
| 478.91M | -42.74% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.19M | -92.56% |
NL
|
